MMR-varicella zoster virus vaccine (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMMR-varicella zoster virus vaccine (GlaxoSmithKline)
Drug Alias NamePriorixTetraMMR+varicella vaccinePriorix-TetraGSK-208136
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMumpsMeasles +[5
Global Approved IndicationsRubellaMumpsMeasles +[4
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2006/07/01
Country/TerritoryCzechiaCanadaSlovakia +[14
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsRubellaMumpsMeasles +[4
Inactive IndicationsChickenpox

Other Information

ATC CodeJ07BD54
Related LinksN/A